Anika Therapeutics (ANIK) Tops Q3 EPS by 22c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.50 +1.56%
Financial Fact:
Interest income (expense), net: 93K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Interest income (expense), net: 93K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q3 EPS of $0.04, $0.22 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $27.8 million versus the consensus estimate of $27.8 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Phillips 66, Marathon Merger Talks Collapsed - Semafor
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
